WuXi Biologics Included in S&P Global Sustainability Yearbook 2025
Inclusion in Global Yearbook for third consecutive year
Leader in Green CRDMO to drive innovation for a healthier future
SHANGHAI, March 10, 2025 /PRNewswire/ -- WuXi Biologics ('WuXi Bio') (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced it has been included in the S&P Global Sustainability Yearbook 2025 ('Yearbook') for its strong sustainability performance in 2024. The company was ranked top in its industry and received a Top 1% S&P Global Corporate Sustainability Assessment (CSA) Score, marking the third year WuXi Biologics has received this highest level of recognition.
The Yearbook aims to distinguish individual companies — within a range of industries — that have demonstrated strong corporate sustainability, based on their S&P Global 2024 CSA Score. Out of the 7,690 companies assessed in the 2024 CSA, only 780 companies, across 62 industries, were recognized as the top performers and selected for inclusion in Yearbook 2025.
Dr. Chris Chen, CEO of WuXi Biologics and Chairman of its ESG Committee, commented, 'We are very pleased to be once again selected for inclusion in the Yearbook, a reflection of our steadfast dedication to enhancing our sustainability performance. As a global leader in Green CRDMO, we consistently deliver ESG excellence, enable partners worldwide to fulfill ESG commitments, and jointly work with all stakeholders to promote responsible practices throughout the entire value chain.'
In the past couple of years, WuXi Biologics has also been named to the 2023 and 2024 Dow Jones Sustainability Indices (DJSI) for its unremitting efforts and notable achievements in promoting sustainable development. In addition, as a participant of United Nations Global Compact (UNGC) and Pharmaceutical Supply Chain Initiative (PSCI), WuXi Biologics proactively contributes to advocating sustainability, and has earned widespread recognition for its efforts. It was granted an MSCI AAA Rating and EcoVadis Platinum Medal for two consecutive years; included in the UNGC 20 Case Examples of Sustainable Development for 20 Years Collection for its world-leading green biologics solutions; recognized as a Sustainalytics industry and regional ESG top-rated company for five consecutive years; named to the CDP Water Security 'A list' and awarded an 'A-" CDP Climate Change score; selected as a Constituent of the FTSE4Good Index Series; and listed in the Hang Seng ESG 50 Index.
About WuXi Biologics
WuXi Biologics (stock code: 2269.HK) is a leading global Contract Research, Development and Manufacturing Organization (CRDMO) offering end-to-end solutions that enable partners to discover, develop and manufacture biologics – from concept to commercialization – for the benefit of patients worldwide.
With over 12,000 skilled employees in China, the United States, Ireland, Germany and Singapore, WuXi Biologics leverages its technologies and expertise to provide customers with efficient and cost-effective biologics discovery, development and manufacturing solutions. As of December 31, 2024, WuXi Biologics is supporting 817 integrated client projects, including 21 in commercial manufacturing (excluding COVID CMO projects).
WuXi Biologics views Environmental, Social, and Governance (ESG) responsibilities as an integral component of our ethos and business strategy, and we aim to be an ESG leader in the biologics CRDMO sector. Our facilities use next-generation biomanufacturing technologies and clean-energy sources. We have also established an ESG committee led by our CEO to steer the comprehensive ESG strategy and its implementation, enhancing our commitment to sustainability.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
32 minutes ago
- Yahoo
The S&P 500 Just Made a Bullish Crossover. Here's Why That Might Not Necessarily Mean a Big Rally Is Coming.
The S&P 500 recently made a very bullish "crossover," which has been known to precede to a strong rally. The last time a similar crossover took place was back in 2023, a year when the index rose by 24%. Investors, however, should consider the full context when analyzing chart trends. 10 stocks we like better than S&P 500 Index › The S&P 500 (SNPINDEX: ^GSPC) has been doing fairly well this year, and has recovered after the early Trump tariff news spooked investors back in April. It's back up around record levels, and recently made a very bullish crossover -- one that it hasn't made in two years. When there's a big "crossover" in stock prices' moving averages for different time frames, that can be a very bullish sign to buy, according to technical analysts who rely on chart patterns. But that doesn't mean an investment or asset is guaranteed to rise in value after such a crossover. It's always important to consider context. Here's why you shouldn't get too excited about what might normally be a very positive indicator for the S&P 500. A "golden cross" occurs when a shorter-term moving average crosses above a longer-term moving average. On the flip side, when the opposite happens, that's referred to as a "death cross," and technical analysts consider it a very bad indicator. Recently, the S&P 500's 50-day moving average crossed above its 200-day moving average, making a golden cross. A death cross did occur earlier this year when "reciprocal tariffs" were announced, but as you can see from the chart above, the S&P 500 has recovered in a relatively short fashion. The last time that a golden cross took place was back in early 2023, a year when the S&P 500 would go on to rally by more than 24%. Investing based on charts alone can be a dangerous strategy because they don't tell you the whole story, and it's important to understand what's going on in the markets, along with the relevant risks. Back in early 2023, when the last golden cross took place, the S&P 500 was coming off a brutal year in 2022 when it plunged by more than 19%. A golden cross then was a good sign that the market was recovering. This time around, however, things are a bit different. If not for the "reciprocal tariffs" that were announced back in April, a death cross probably wouldn't have happened, and neither would this recent golden cross. This is where context is important in analyzing any chart trends. It's not as simple as assuming that because a golden cross has taken place, stocks are destined to go higher. Instead, it looks like the S&P 500 has effectively gotten back to where it was before the threat of tariffs derailed its progress. I definitely wouldn't interpret this as a sign that stocks are likely to go on to major gains, not with the S&P 500 at record levels and with the threat and uncertainty around tariffs still hovering over the markets. The S&P 500 has historically risen in value over the long term, and that's the only real trend you need to worry about with the index. In fact, the death cross that took place earlier this year highlights a significant weakness in relying on technical analysis and charts alone. By simply looking at the earlier chart back in April, you may not have expected a bearish crossover to suddenly take place. If, however, you were following market-related news and were aware that wide-scale tariffs were about to be put in place, you may have anticipated a significant pullback in the markets due to worsening investor sentiment. Charts can be useful tools in assessing how a stock or asset is doing, but you shouldn't base your investing decision on what a trend may suggest is happening. The good news, however, is that with a simple buy-and-hold strategy, you can ignore chart trends and just hang on for the long haul. This is where tracking the S&P 500 through exchange-traded funds can be an easy, no-nonsense way to grow your portfolio over the long term without having to worry about what's happening in the markets on a day-to-day basis. Before you buy stock in S&P 500 Index, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and S&P 500 Index wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $674,432!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,005,854!* Now, it's worth noting Stock Advisor's total average return is 1,049% — a market-crushing outperformance compared to 180% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of July 7, 2025 David Jagielski has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. The S&P 500 Just Made a Bullish Crossover. Here's Why That Might Not Necessarily Mean a Big Rally Is Coming. was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Upturn
3 hours ago
- Business Upturn
U.S. Energy Regulations Accelerate Mining Transformation: NR7 Miner Pioneers Zero-Carbon Bitcoin Mining Era
New York, NY, July 12, 2025 (GLOBE NEWSWIRE) — Stricter cryptocurrency mining energy reporting requirements from the U.S. Energy Information Administration (EIA) are fundamentally reshaping the industry. At this pivotal juncture, NR7 Miner ( delivers a compliant path for investors to align with regulatory trends and environmental responsibility through its innovative zero-carbon cloud mining solution. Policy-Driven Shift Makes Green Mining Essential Heightened U.S. demands for mining energy transparency highlight the high-carbon footprint of traditional operations. NR7 Miner's breakthrough technology directly addresses this pain point: the platform strategically integrates rigorously certified idle clean energy sources (wind, solar, hydro) across North America, ensuring every kilowatt-hour carries traceable zero-carbon credentials. Independent audits verify that NR7 Miner users reduce their carbon footprint by over 90% compared to grid-dependent mining. Technology Empowerment: Hardware-Free, High-Efficiency Bitcoin Participation NR7 Miner's core advantage liberates individual players Zero Hardware Investment: Eliminates the need for costly ASIC miners, maintenance, or high electricity bills. Flexible Contracts: Diverse hashrate contracts adapt to varying investment scales and durations. [Click here to view available contracts] Transparency & Efficiency: Advanced algorithmic hashrate allocation maximizes resource utilization. Users track real-time earnings and energy sources via an intuitive dashboard. ESG & Profitability: Building a Sustainable Crypto Future 'U.S. policy isn't a constraint—it's a clear signal for our sustainable future,' stated the CEO of NR7 Miner. 'Our platform enables mainstream investors to participate in Bitcoin's green expansion without technical barriers, while earning competitive returns. This perfectly aligns regulatory compliance, environmental stewardship, and economic benefit.' Act Now: Shape the Future of Green Mining As U.S. crypto mining regulation and green transition accelerate, NR7 Miner sets the new standard for zero-carbon, accessible Bitcoin mining participation. About NR7 Miner: NR7 Miner ( is a leading zero-carbon cloud hashrate provider, connecting clean energy to the Bitcoin network through innovative technology. We deliver efficient, transparent, and responsible digital asset acquisition globally while strictly adhering to ESG principles to advance crypto sustainability. Resources: Explore Zero-Carbon Mining: Disclaimer: Cryptocurrency mining is subject to market risk. Past performance does not guarantee future returns. Participants should assess their personal risk tolerance. Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash
Yahoo
5 hours ago
- Yahoo
Here's Why Aehr Test Systems Stock Had a Wild Ride in the First Half of 2025
Aehr's traditional end markets are suffering from a slowdown in electric vehicle investment. The company has successfully opened up new markets that could potentially be far larger than its core silicon carbide end market. 10 stocks we like better than Aehr Test Systems › Shares in Aehr Test Systems (NASDAQ: AEHR) slumped by 22.2% in the first half of 2025, according to data provided by S&P Global Market Intelligence. That figure may surprise investors, not least because it's a long, long way from telling the whole story of a stock that declined 56% in the first three months of 2025 only to rise 77.4% in the last three months of the half-year. The fall and rise of the stock mirrors the narrative around it and its end markets. The company recently reported its full-year financial 2025 earnings. For the sake of clarity, its financial year ends on May 30. Going back to focusing on the first six months of the calendar year, Aehr started the year with most investors thinking of it as a company focused on the silicon carbide (SiC) wafer-level burn-in (WLBI) market, and with good reason, because the SiC WLBI market accounted for 90% of its sales in its financial year 2024. ON Semiconductor (NASDAQ: ON) has previously been named as a significant customer, and its sales slowdown has mirrored a broader slowdown in the SiC market, principally in the electric vehicle (EV) market. A combination of an ongoing relatively high interest rate and a correction from a previous boom in EV spending meant Aehr couldn't rely on the SiC WLBI market for growth in its financial 2025. Indeed, CEO Gayn Erickson recently outlined that SiC WLBI "made up less than 40% of our revenue this fiscal '25." As such, the story of Aehr's first three months was disappointing, as its EV end market for SiC WLBI equipment continued to weaken. The significant turnaround in the stock's fortunes in 2025 occurred in the third-quarter earnings report in April, when management announced it was expanding into new markets and was on track to generate 35% of its revenue (later confirmed) from the artificial intelligence (AI) processor burn-in market. In addition, management said it had "four customers representing over 10% of revenue, and three of these are new markets," including WLBI of gallium nitride (GaN) semiconductor supply to the automotive market. Furthermore, on the fourth-quarter earnings release, Erickson said it had secured "a major hyperscaler" as a first production AI customer in the packaged part burn-in (PPBI) market. While Aehr isn't naming these significant customers, a slide deck of its customers includes names like Microsoft, Alphabet's Google, Nvidia, ON Semiconductor, and Infineon, among many others. Management believes its AI end markets are potentially 3 to 5 times larger than its traditional SiC markets, and that optimism is fueling the current stock price strength. Before you buy stock in Aehr Test Systems, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Aehr Test Systems wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $671,477!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,010,880!* Now, it's worth noting Stock Advisor's total average return is 1,047% — a market-crushing outperformance compared to 180% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of July 7, 2025 Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool's board of directors. Lee Samaha has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Alphabet, Microsoft, and Nvidia. The Motley Fool recommends ON Semiconductor and recommends the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool has a disclosure policy. Here's Why Aehr Test Systems Stock Had a Wild Ride in the First Half of 2025 was originally published by The Motley Fool
